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selayed Hyperenhancement
agnetic Resonance Imaging
or Sudden Cardiac Death
isk Stratification in
ypertrophic Cardiomyopathy
e have read with great interest the consensus guidelines intro-
uced by Goldberger et al. (1) concerning the evaluation of
oninvasive risk stratification techniques for identification of
atients at risk for sudden cardiac death (SCD). Concerning
ypertrophic cardiomyopathy (HCM), the authors conclusively
upport that the use of electrocardiography, signal-averaged elec-
rocardiography, treadmill exercise test, and 2-dimensional echo-
ardiography, along with obtaining a detailed personal and familial
istory, can successfully assess risk for SCD, even though no
andomized trials exist using these parameters (1).
SCD among HCM patients is mainly connected to the occur-
ence of ventricular tachycardia/ventricular fibrillation (VT/VF)
2). Many studies suggest that the extent of myocardial disarray-
brosis, predisposing to re-entry phenomena as part of a general
rrhythmogenic tendency, constitutes the main stimulus for
T/VF incidence (3,4). Delayed hyperenhancement magnetic
esonance imaging (MRI) accurately detects myocardial fibrosis
egree, and a statistically powerful correlation between fibrosis
xtent and incidence of VT/VF in HCM seems to have been
stablished by previous studies (5,6). However, the role of delayed
yperenhancement MRI as well as its diagnostic and prognostic
tility in assessment of SCD risk are not discussed in this
onsensus document. Obviously, more cohort studies are needed to
stablish an etiological relationship between scar size and the
ossibility of sudden death. Notwithstanding, delayed hyperen-
ancement MRI along with the aforementioned “screening” prac-
ices could offer a more precise estimation of risk for SCD in
CM patients.
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n Call at the
isconsin Heart Hospital
had just gotten home from rounds. While opening the Sunday
ewspaper, the phone rang. Dr. Clyde said, “Linda Bonobo was very
ethargic and wouldn’t get up for breakfast. Her breathing is labored
nd her edema is worse. We’re taking her to the hospital now.”
Linda is a 51-year-old insulin-dependent diabetic, mother of 12,
ho presented a month ago with edema, ascites, lethargy, anorexia,
nd shortness of breath. Echocardiography showed anteroapical
yskinesis of the left ventricle, and ejection fraction 35%. She was
reated with furosemide, lisinopril, metoprolol, and aspirin. Her
ppetite and level of physical activity improved. Her abdomen seemed
ess protuberant.
Linda has no prior history of heart disease. She has had insulin-
ependent diabetes for 5 years. Her urine has recently been negative
or glucose. Her low-density lipoprotein was 72 mg/dl, and her
igh-density lipoprotein was 142 mg/dl. No family history is avail-
ble: Linda was born in the wild in the jungles of the Democratic
epublic of Congo. Heart disease is a frequent cause of death in
onobos living in captivity. Being eaten by humans as “bush meat” is
ften the cause of death in wild bonobos. Bonobos are an endangered
pecies.
I parked in the Heart Hospital lot and walked across the street tohe Milwaukee Zoo. The Animal Health Center is just inside the
